| Dr Firas R Karmo, MD | |
|
44555 Woodward Ave 103, Pontiac, MI 48341-5032 | |
| (248) 858-6777 | |
| Not Available |
| Full Name | Dr Firas R Karmo |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 36 Years |
| Location | 44555 Woodward Ave 103, Pontiac, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679673289 | NPI | - | NPPES |
| 4560210 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 100858 (Wisconsin) | Secondary |
| 174400000X | Specialist | 4301066100 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Entity Name | Karmo Aesthetic Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073711438 PECOS PAC ID: 6709976673 Enrollment ID: O20071214000608 |
News Archive
His decision rejected the "argument that Congress lacked the power to create the legislation's 'individual mandate,' which requires virtually all Americans to purchase health insurance," The Washington Post reports. "Other federal courts have already dismissed some challenges to the law on technical grounds — ruling, for instance, that the plaintiffs lacked standing.
An international team of transplant physicians has shown that the investigational drug belatacept (LEA29Y) preserves transplanted kidney function as effectively as cyclosporine, the drug most commonly used to prevent the immune system from rejecting transplanted organs.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Scientists have made a significant discovery about how the body defends itself against snail fever, a parasitic worm infection common in developing countries.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Firas R Karmo, MD 44555 Woodward Avenue Suite 103, Pontiac, MI 48341-5032 Ph: (248) 858-3777 | Dr Firas R Karmo, MD 44555 Woodward Ave 103, Pontiac, MI 48341-5032 Ph: (248) 858-6777 |
News Archive
His decision rejected the "argument that Congress lacked the power to create the legislation's 'individual mandate,' which requires virtually all Americans to purchase health insurance," The Washington Post reports. "Other federal courts have already dismissed some challenges to the law on technical grounds — ruling, for instance, that the plaintiffs lacked standing.
An international team of transplant physicians has shown that the investigational drug belatacept (LEA29Y) preserves transplanted kidney function as effectively as cyclosporine, the drug most commonly used to prevent the immune system from rejecting transplanted organs.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
Scientists have made a significant discovery about how the body defends itself against snail fever, a parasitic worm infection common in developing countries.
› Verified 1 days ago